TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
AVIR

Atea Pharmaceuticals Inc

Healthcare · Biotechnology

5.40$ +1.9% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet AVIR
Line item 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
99.5% 99.3% 100.0% 99.9% 99.1% 99.2% 99.5% 98.7%
98.9% 98.1% 98.4% 98.9% 97.0% 24.2% 13.9% 30.4%
98.9% 98.1% 98.4% 98.9% 97.0% 97.2% 97.9% 95.8%
0.7%
0.2% 0.2% 0.0% 0.0% 0.6%
203.7% 324.6% 36.6% 8.1% 3.9% 6.7% 5.6% 12.6%
5.0% 11.0% 36.6% 7.4% 2.8% 5.4% 4.0% 12.6%
-0.6% 0.9% 0.0% 0.1% 0.1% 0.2% 0.3%
1.1% 2.5% 0.0% 0.6% 0.4% 0.7% 1.0% 4.1%
-103.7% -224.6% 63.4% 91.9% 96.1% 93.3% 94.4% 87.4%
-115.3% -245.6% -7.5% 7.2% -9.0% -32.9% -78.4% -165.8%
28.9% 374.3% 9.5% 11.4% 12.5% 14.0% 18.1% 25.9%

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?